A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206-Reference-Cited by-同舟云学术

A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206

Published:2018-02-22 Issue:2 Volume:13 Page:e0193344
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chorner Paige M.,Moorehead Roger A.^ORCID

Funder

Canadian Cancer Society Research Institute

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Cancer statistics, 2015;RL Siegel;CA: a cancer journal for clinicians,2015

2. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis;H Wao;Syst Rev,2013

3. Somatic mutations affect key pathways in lung adenocarcinoma;L Ding;Nature,2008

4. Epidermal growth factor receptors in non-small cell lung cancer;D Veale;Br J Cancer,1987

5. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer;JP Koivunen;Clinical cancer research: an official journal of the American Association for Cancer Research,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoresistance Mechanisms in Non-Small Cell Lung Cancer—Opportunities for Drug Repurposing;Applied Biochemistry and Biotechnology;2023-09-18

2. Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines;Biomedicines;2023-08-28

3. Using ChEMBL to Complement Schistosome Drug Discovery;Pharmaceutics;2023-04-28

4. A review on the role of cyclin dependent kinases in cancers;Cancer Cell International;2022-10-20

5. Advances in Immunosuppressive Agents Based on Signal Pathway;Frontiers in Pharmacology;2022-05-26